Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lung Cancer Research Studies
TopicLeading institutions, researchers & key papers
This cluster of papers represents a comprehensive exploration of small cell lung cancer, covering topics such as genomic profiles, immunotherapy, chemotherapy, prognostic factors, biomarkers, targeted therapy, clinical trials, metastasis, and tumor markers.
879
Works
IDs:OpenAlex
How has Lung Cancer Research Studies's publication output changed over time?
ScholarIQpublication output · 1979–2021
Output grew200% over the shown period — from 1 works in 1979 to 3 in 2021.
1
1
2
1
2
2
2
1
3
197920062012201420152018201920202021
What are the most-cited papers on Lung Cancer Research Studies?
ScholarIQmost cited works
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J. Hochmair, Florian Huemer, György Losonczy, Melissa L. Johnson, Makoto Nishio, Martin Reck, Tony Mok, Sivuonthanh Lam, David S. Shames, Juan Liu, Beiying Ding, Ariel López-Chávez, Fairooz F. Kabbinavar, Wei Lin, Alan Sandler, Stephen V. Liu
New England Journal of Medicine. 20183,565 CitationsOPEN ACCESS
Comprehensive genomic profiles of small cell lung cancer
Julie George, Jing Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lü, Lynnette Fernandez‐Cuesta, Graziella Bosco, Christian Müller, Ilona Dahmen, Nadine S. Jahchan, Kwon-Sik Park, Dian Yang, Anthony N. Karnezis, Dedeepya Vaka, Angela Torres, Maia Segura‐Wang, Jan O. Korbel, Roopika Menon, Sung‐Min Chun, Deokhoon Kim, Matt Wilkerson, Neil Hayes, David Engelmann, Brigitte M. Pützer, Marc Bos, Sebastian Michels, Ignacija Vlašić, Danila Seidel, Berit Pinther, Philipp Schaub, Christian Becker, Janine Altmüller, Jun Yokota, Takashi Kohno, Reika Iwakawa, Koji Tsuta, Masayuki Noguchi, Thomas Muley, Hans Hoffmann, Philipp A. Schnabel, Iver Petersen, Yuan Chen, Alex Soltermann, Verena Tischler, Chang‐Min Choi, Yong‐Hee Kim, Pierre P. Massion, Yong Zou, Dragana J. Jovanović, Milica Kontić, Gavin Wright, Prudence A. Russell, Benjamin Solomon, Ina Koch, Michael Lindner, Lucia Anna Muscarella, Annamaria la Torre, John K. Field, Marko Jakopović, Jelena Knežević, Esmeralda Castaños‐Vélez, Luca Roz, Ugo Pastorino, O.T. Brustugun, Marius Lund‐Iversen, Erik Thunnissen, Jens Köhler, Martin Schüler, Johan Botling, Martin Sandelin, Montse Sánchez‐Céspedes, Helga B. Salvesen, Viktor Achter, Ulrich Lang, Magdalena Bogus, Peter M. Schneider, Thomas Zander, Sascha Ansén, Michael Hallek, Jürgen Wolf, Martin Vingron, Yasushi Yatabe, William D. Travis, Peter Nürnberg, Christian Reinhardt, Sven Perner, Lukas C. Heukamp, Reinhard Büttner, Stefan A. Haas, Élisabeth Brambilla, Martin Peifer, Julien Sage, Roman K. Thomas
Nature. 20152,417 CitationsOPEN ACCESS
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Norah J. Shire, Haiyi Jiang, Jonathan W. Goldman, Emilio Batagelj, Ignacio Casarini, Anea Viviana Pastor, S. Sena, Juan José Zarbá, Otto C. Burghuber, Sylvia Hartl, Maximilian J. Hochmair, Bernd Lamprecht, Michael Studnicka, Luís Alberto Schlittler, Fabrício Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Baldotto, Cláudia Vaz de Melo Sette, Mauro Zukin, Nikolay Conev, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Xing Li, Zongan Liang, Lin Zhong, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Libor Havel, Vı́tězslav Kolek, Leona Koubková, Jaromı́r Roubec, Jana Skřičková, Milada Zemanová, C. Chouaïd, Werner Hilgers, H. Léna, Denis Moro‐Sibilot, G. Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohé, Eckart Laack, Susanne Lang, Jens Panse, Niels Reinmuth, Christian Schulz
The Lancet. 20192,246 Citations
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
Ramaswamy Govindan, Nathan Page, Daniel Morgensztern, William L. Read, Ryan M. Tierney, Anna Vlahiotis, Edward L. Spitznagel, Jay F. Piccirillo
Journal of Clinical Oncology. 20061,859 CitationsOPEN ACCESS
Small-cell lung cancer
Charles M. Rudin, Élisabeth Brambilla, Corinne Faivre‐Finn, Julien Sage
Nature Reviews Disease Primers. 20211,575 CitationsOPEN ACCESS
Where is Lung Cancer Research Studies research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Lung Cancer Research Studies is open access?
ScholarIQopen access share
80%OPEN ACCESS
Gold
7%
Green
33%
Hybrid
13%
Bronze
27%
Closed
20%
Related on ScholarIQ
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Paper
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Paper
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Paper
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Paper
Osimertinib in Untreated <i>EGFR</i> -Mutated Advanced Non–Small-Cell Lung Cancer
Paper
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
Paper